Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
Ali ZA, Maehara A, Généreux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, Guagliumi G, Meraj PM, Alfonso F, Samady H, Akasaka T, Carlson EB, Leesar MA, Matsumura M, Ozan MO, Mintz GS, Ben-Yehuda O, Stone GW; ILUMIEN III: OPTIMIZE PCI Investigators.
Lancet. 2016 Nov 26;388(10060):2618-2628. doi: 10.1016/S0140-6736(16)31922-5. Epub 2016 Oct 30.
Is coronary artery tortuosity a predisposing factor for drug-eluting stent restenosis?
Levent F, Senoz O, Emren SV, Emren ZY, Gediz RB.
Herz. 2022 Feb;47(1):73-78. doi: 10.1007/s00059-021-05036-z. Epub 2021 Apr 24.
Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
Nairooz R, Saad M, Sardar P, Aronow WS.
Heart. 2017 Jul;103(14):1096-1103. doi: 10.1136/heartjnl-2016-310886. Epub 2017 Jan 23.
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
Bønaa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nygård O, Nilsen DW, Kløw NE, Uchto M, Trovik T, Bendz B, Stavnes S, Bjørnerheim R, Larsen AI, Slette M, Steigen T, Jakobsen OJ, Bleie Ø, Fossum E, Hanssen TA, Dahl-Eriksen Ø, Njølstad I, Rasmussen K, Wilsgaard T, Nordrehaug JE; NORSTENT Investigators.
N Engl J Med. 2016 Sep 29;375(13):1242-52. doi: 10.1056/NEJMoa1607991. Epub 2016 Aug 29.
Coronary artery bypass graft surgery versus drug-eluting stent implantation for high-surgical-risk patients with left main or multivessel coronary artery disease.
Chang M, Lee CW, Ahn JM, Cavalcante R, Sotomi Y, Onuma Y, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Serruys PW, Park SJ.
Eur J Cardiothorac Surg. 2017 May 1;51(5):943-949. doi: 10.1093/ejcts/ezw370.
Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis.
Wang Z, Gong Y, Fan F, Yang F, Qiu L, Hong T, Huo Y.
Ren Fail. 2020 Nov;42(1):107-112. doi: 10.1080/0886022X.2019.1710187.
[Prognostic analysis of drug-eluting stent implantation and coronary artery bypass grafting in patients with unprotected left main coronary artery disease complicated with chronic renal failure].
Pan Y, Mu Y, Zhang Y, He J, Qiu Q.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Oct;32(10):1203-1207. doi: 10.3760/cma.j.cn121430-20200518-00391.
Effect of lipoprotein(a) levels on long-term outcome in octogenarians with coronary artery disease after drug-eluting stent implantation.
Hu B, Zhou Y, Shi D, Zhao Y, Jia D, Yang S, Jia S, Xu X, Ma X.
Rev Cardiovasc Med. 2022 Mar 1;23(3):79. doi: 10.31083/j.rcm2303079.
Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
Kang SH, Park KH, Choi DJ, Park KW, Chung WY, Lim C, Kim KB, Kim HS.
Am J Cardiol. 2010 Feb 1;105(3):343-51. doi: 10.1016/j.amjcard.2009.09.036.
Long-term outcomes of IVUS-guided and angiography-guided drug-eluting stent implantation for left main coronary artery disease: a retrospective consort study.
Yang Q, Ma X, Wang Y.
J Cardiothorac Surg. 2024 Jul 1;19(1):407. doi: 10.1186/s13019-024-02800-0.
